ArticleFrontiers in psychiatry2025
A virtual reality-based multimodal framework for adolescent depression screening using machine learning.
Article in Frontiers in psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Artificial Intelligence-Integrated Virtual Reality in Mental Health Care: A Scoping Review of Evidence, Clinical Applications, and Future Directions.Journal of clinical medicine · 2026Review
- Positive psychology 4.0: a science of consequence for a world that can no longer wait.Frontiers in psychology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Major depressive disorder (MDD) in adolescents poses an increasing global health concern, yet current screening practices rely heavily on subjective reports. Virtual reality (VR), integrated with multimodal physiological sensing (EEG+ET+HRV), offers a promising pathway for more objective diagnostics. Methods: In this case-control study, 51 adolescents diagnosed with first-episode MDD and 64 healthy controls participated in a 10-minute VR-based emotional task. Electroencephalography (EEG), eye-tracking (ET), and heart rate variability (HRV) data were collected in real-time. Key physiological differences were identified via statistical analysis, and a support vector machine (SVM) model was trained to classify MDD status based on selected features. Results: Adolescents with MDD showed significantly higher EEG theta/beta ratios, reduced saccade counts, longer fixation durations, and elevated HRV LF/HF ratios (all p <.05). The theta/beta and LF/HF ratios were both significantly associated with depression severity. The SVM model achieved 81.7% classification accuracy with an AUC of 0.921. Conclusions: The proposed VR-based multimodal system identified robust physiological biomarkers associated with adolescent MDD and demonstrated strong diagnostic performance. These findings support the utility of immersive, sensor-integrated platforms in early mental health screening and intervention. Future work may explore integrating the proposed multimodal system into wearable or mobile platforms for scalable, real-world mental health screening.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.